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Autophagy is an innate anti-microbial host defense that maintains tissue homeostasis. 
Autophagy is negatively regulated by the nutrient-sensing mTORC1 complex. In this study, we 
examined the regulatory mechanisms of autophagy and inflammasome activation during 
Ehrlichia infection. Monocytic Ehrlichia is a Gram negative intracellular bacterial pathogen that 
causes fatal human monocytic ehrlichiosis. Ehrlichia lacks LPS, but induces inflammasome 
activation leading to acute liver damage. In humans, the potentially fatal human monocytic 
ehrlichiosis (HME) mimics sepsis and toxic shock-like syndrome [1, 2], making Ehrlichia a 
viable model system for these conditions in the absence of LPS. During virulent Ehrlichia 
infection confocal data shows that autophagy increased with infection, despite clear activation of 
the autophagy inhibitor mTORC1. This is likely due to a balance of mTORC1 dependent and 
independent autophagy. Employing bone marrow derived macrophages (BMM) from mice 
deficient in MyD88 and TLR9 we reveal a novel signaling pathway for IOE mediated autophagy 
regulation and inflammasome activation centered around IFNβ production. We have previously 
shown that the virulent Ehrlichia strain Ixodes ovatus Ehrlichia (IOE) expresses higher levels of 
IFNβ than the avirulent strain Ehrlichia muris (EM) [3]. When IFNβ is added to BMM mTORC1 
activation increases, a phenomenon further increased when IFNβ is added to IOE infected BMM. 
Both IOE and IFNβ mediated mTORC1 activation are abrogated by knockout of the TLR9 
receptor. This placed IFNβ upstream of TLR9 in the IOE mediated mTORC1 signaling pathway. 
As both TLR9 is activated by dsDNA, we have hypothesized that these receptors are activated 
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are activated by mitochondrial DNA released in response to IFNβ mediated DAMP production. 
These data suggest that LPS-negative Ehrlichia regulates autophagy with mTORC1, and that this 
mTORC1 activation is achieved via IFNβ mediated TLR9. Our findings reveal a novel regulation 
of autophagy and the inflammasome in macrophages via MyD88 and mTORC1 during infection 
with intracellular pathogens. 
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1.0  INTRODUCTION 
We examined the effect of bacterial infection on inflammasome activation and autophagy in 
murine primary macrophages using Ixodes ovatus Ehrlichia (IOE); a Gram negative obligate 
intracellular bacterium lacking lipopolysaccharide (LPS). We show that IOE infection in 
macrophages results in MYD88-dependent mTOR activation and inhibition of autophagy flux, a 
response enhanced by IFNb stimulation. Additionally, MYD88 is critical for IOE induced 
inflammasome activation, including increases in TNF-α and IL-1β production. 
1.1 EHRILICHIA AND THE INNATE IMMUNE RESPONSE 
Ehrlichia is an obligate intracellular gram-negative bacteria which primarily proliferates in 
monocytes and macrophages, resides in endosomal compartments, and also infects hepatic and 
splenic tissue [4]. The emerging infectious disease Human Monocytotropic Ehrlichiosis (HME) 
results from infection with the human specific Ehrlichia strain Ehrlichia chaffeensis [5]. HME 
severity varies dramatically, from asymptomatic to fatal toxic-shock-like syndrome with multi-
organ failure [6]. The clinical and pathological manifestations of HME closely resemble those 
observed in the murine model of fatal Ehrlichiosis infection with the highly virulent strain (IOE), 
making murine IOE infection an excellent model for studies of HME. Additionally, Ehrlichia 
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lacks the lipopolysaccharide (LPS) and peptidoglycan classically produced by gram negative 
bacteria. To maintain outer membrane integrity Ehrlichia instead acquires cholesterol from the 
host cell membrane [7]. This makes Ehrlichia more applicable as a broader model system 
compared to any LPS producing bacteria, which will produce an immune response largely 
dependent on the toxicity of LPS. Ehrlichia species employ various mechanisms to evade host 
immune responses and proliferate within the cell, thus facilitating bacterial dissemination. For 
example, Ehrlichia chaffeensis directly inhibits production of cytokines such as IL-12 and IFNγ, 
which are involved in cell-mediated defense against intracellular bacteria [8]. 
Innate immune cells respond to pathogen-associated factors via expression of toll-like 
receptors (TLRs) and cytosolic nucleotide-binding oligomerization domain-like receptors 
(NLRs). TLRs and NLRs represent a group of pattern recognition receptors (PRRs) which are 
critical to both host innate immune response, and adaptive immune response [9]. TLRs and 
NLRs recognize and respond to a variety of pathogen associated molecular patterns (PAMPs) 
[10]such as LPS, lipoproteins, nucleic acids, and danger associated molecular patterns (DAMPs) 
[11] such as ROS. Recognition of PAMPS or DAMPS by NLRs triggers the assembly of 
inflammasomes. Inflammasomes are multiprotein complexes necessary for the maturation of 
inflammatory cytokines such as IL-1β or IL-18 [9]. 
Inflammatory responses can be broken down into two broad categories, canonical and 
non-canonical. These categories are distinguished primarily by the active caspase, component 
which is cleaved and integrated into the resulting inflammasome complex. Canonical 
inflammatory response leads to direct caspase 1 activation, where as non-canonical inflammatory 
response results in activation of caspase 11 [12] in mice or its human analog caspase 4 [13]. 
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These TLRs then activate the downstream molecules MyD88 or TRIF [14], which elicit a 
signaling cascade that induces inflammasome activation, and inhibits autophagy. We have 
chosen to focus on TLR9 and MyD88 as both display increased mRNA levels in IOE infected 
macrophages. This induction is likely tied to IOE’s high virulence, as IOE mediated MyD88 and 
TLR9 expression is significantly higher than that induced by the less virulent Ehrlichia strain 
Ehrlichia muris (EM). TLR9 senses bacterial DNA in the endosome, as well as fragmented 
mitochondrial DNA released as a byproduct of cell damage [15]. It is possible that other TLRs 
also play a lesser role in IOE dependent TLR signaling, except for the LPS-sensing TLR4  [16], 
but TLR9 appears to play a primary role in IOE mediated cell signaling.  
1.2 AUTOPHAGY 
Innate host response utilizes autophagy to eliminate intracellular pathogens, thus autophagy may 
mediate IOE clearance.  Autophagy is a metabolic function which can also act as an immune 
effector to mediate pathogen clearance [17]. During autophagy, damaged cell components are 
encased in membranous autophagosomes. These autophagosomes then fuse with lysosomes, and 
the cargo is degraded by the contents of the highly acidic lysosome. The regulatory mechanisms 
for autophagy are very complex, but in general terms autophagy can be broken down in to three 
basic steps: induction, elongation, and fusion/degradation [17]. When studying autophagy, the 
progression through these steps is often characterized by the lipidation state of the protein LC3, 
otherwise known as the conversion of LC3I to LC3II. During elongation, when the potential 
autophagosomes membrane expands and closes, LC3I is brought to the autophagosome 
membrane by the autophagy facilitator protein ATG3. Once LC3I binds to the autophagosomal 
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membrane it becomes lipidated, the molecular weight of the protein changes, and this new 
compound can be used to track the autophagosome through the processes of autophagosome 
formation, fusion with the lysosome, and degradation [18-20]. For this study, we have focused 
on mTORC1 activation as determined by phosphorylation of the ribosomal protein S6, which 
inhibits autophagosome membrane formation, as well as lipidation, localization, and degradation 
of the autophagy proteins p62 and LC3. 
 
1.2.1 mTORC dependent autophagy  
Mammalian target of rapamycin complex 1 (mTORC1), a member of the phosphoinositide 3-
kinase PI3K family, is a negative regulator of autophagy. mTOR kinase signaling acts as an 
integration point for various TLR and cytokine receptor signals in the immune 
microenvironment. Many cellular signals converge on mTOR complex 1 (mTORC1) to regulate 
autophagy induction, or the formation of the initial autophagosomal membrane[18]. This 
includes signaling through the mTORC2 dependent serine/threonine kinase Akt. Phosphorylation 
of Akt modulates autophagic activity regulated through the PI3K pathway. Activation of the 
metabolic sensor mTOR, specifically the complex mTORC1, blocks autophagy flux by 
inhibiting the complexing of beclin-1 and ULK which are essential proteins for autophagosome 
formation [21]. mTORC1 is inhibited by amino acid starvation and cell stress as mechanisms for 
increasing autophagy during times of metabolic need. This mechanism may also be employed to 
contain and destroy bacteria in infected cells. We employ IOE as a broad model for innate 
immune response. 
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1.2.2 mTORC independent autophagy 
mTORC independent autophagy occurs through one of three known pathways: Ca2+/calpan, 
cAMP/Epac/Inositol, and JNK1/Beclin-1/PI3KC3 [22]. Similar to mTORC dependent autophagy, 
mTORC independent autophagy has been shown in both infected and naïve cells, with both 
naive Atp6ap2 knockout hepatocytes and bluetounge virus (BVT) infected cells displaying 
simultaneous mTORC1 activation and high autophagy rates [23],[24] as shown by confocal 
microscopy and LC3 accumulation respectively. In our system mTOR independent autophagy 
through the calpan pathway seems most probably, as the Ca2+ sensing inherent in this pathway 
provides a clear connection to Ehrlichia pathology [25], as well as a potential avenue for 
intervention through mitochondrial damage [26]. This study provides novel distinct regulation of 
autophagy and inflammasome by MyD88 in different target cells employing a non LPS-bacterial 
infection model. 
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2.0  MATERIALS AND METHODS 
2.1 ETHICS STATEMENT 
This study was carried out in strict accordance with the recommendations in the Guide for the 
Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was 
approved by the Committee on the Ethics of Animal Experiments of the University of Pittsburgh 
in accordance with the institutional guidelines for animal  
welfare. 
2.2 MICE AND EHRLICHIA INFECTION 
Female 8 to 12 weeks old mice of the C57Bl/6 background deficient in TLR 9 (TLR 9-/-) as well 
as wild type (WT) mice were obtained from Jackson Laboratories (Bar Harbor, ME). All animals 
were housed under specific pathogen-free conditions at the Animal Research Facility in the 
University of Pittsburgh. 
The highly virulent monocytic strain of Ehrlichia, Ixodes ovatus Ehrlichia (IOE) was 
provided by Dr. Yasuko Rikihisa (Ohio State University, Columbus, OH). IOE stock was 
propagated by passage through wild type C57BL/6 mice. Single-cell suspensions from spleens 
harvested from mice 7 days post-infection (p.i.) were stored in sucrose and potassium phosphate 
(SPK) buffer (0.5 M K2HPO4, 0.5 M KH2PO4, and 0.38 M sucrose) in liquid nitrogen and used 
as stocks. Mice were infected by intraperitoneal (i.p.) injection with a high dose of IOE (103-
104 organisms/mouse). At 7 days p.i., mice per group were sacrificed, and spleens and livers 
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were harvested for further analysis. For survival experiments, mice were monitored daily for 
signs of illness and survival. 
2.3 ISOLATION AND INFECTION OF BONE MARROW DERIVED 
MACROPHAGES  
Bone marrow was isolated as previously described [27] from naive WT, TLR2-/-, TLR9-/-, and 
STING-/- mice. Briefly, femurs were excised and flushed under aseptic conditions. Bone marrow 
cells were seeded in 100 mm petri dishes at 1x105 cells/10 ml/dish in DMEM/F12-GlutaMAX 
(Invitrogen) supplemented with 10% FBS (Invitrogen), 20 ng/ml MCSF (PeproTech), 10 mM 
Hepes (Invitrogen), and 10 mM glutamine (Invitrogen). Approximately 4 ml of fresh media was 
added after 3 days of culture. On day 6, cells were collected and the number of BMM was 
determined by flow cytometry and staining with fluorophore conjugated antibodies specific to 
CD11b and CD11c. The number of CD11c-CD11b+ BMM isolated by this method was ~ 95%.  
BMM collected on day 6 were seeded into 12 well plates for 20 h prior to infection at a density 
of 106 cells/well in DMEM/F12 (Invitrogen) supplemented with 5% FBS, 20 ng/ml MCSF, 10 
mM Hepes. 
Cell-free IOE organisms were prepared from IOE-infected splenocytes as previously 
described (Ismail, et al, 2004JI).  IOE organisms were added to the BMM cultures at multiplicity 
of infection (MOI) of 0.5. When indicated, cells were pretreated for 1 h with recombinant IFNβ 
(400 units/ml), in the presence or absence of IOE. Cells were collected 24 h post-infection, and 
protein extracted for further analysis by western blot. Supernatants were collected and stored at 
−80°C for cytokine analysis.  
 8 
2.4 BACTERIAL BURDEN MEASUREMENT USING QUANTITATIVE REAL-TIME 
PCR 
Total DNA was isolated from liver and spleen tissues using the DNeasy Blood and Tissue kit 
(QIAGEN). Bacterial burden was determined using an iCycler IQ multicolor real-time detection 
system (Bio-Rad Laboratories, Hercules, CA) and primers and probes for the IOE dsb gene as 
previously described (Stevenson et al). The primers and probes used are as follows: IOE dsb 
forward: 5′-CAG GAT GGT AAA GTA CGT GTG A-3′; IOE dsb reverse: 5′- TAG CTA AYG 
CTG CCT GGA CA-3′; IOE probe: (6FAM)-AGG GAT TTC CCT ATA CTC GGT GAG GC-
(MGB-BHQ). The eukaryotic housekeeping gene gapdh was amplified using the following 
primers/probes: GAPDH forward: 5′-CAA CTA CAT GGT CTA CAT GTT C-3′; GAPDH 
reverse: 5′-TCG CTC CTG GAA GAT G-3'; GAPDH probe: (6FAM)-CGG CAC AGT CAA 
GGC CGA GAA TGG GAA GC-(MGB-BHQ). The comparative cycle threshold (CT) method 
was used to determine the bacterial burden. The results were normalized to the levels of 
expression of the gapdh in the same sample and expressed as copy number per 104 copies 
of gapdh. The results were considered negative for Ehrlichia DNA if CT ≥ 38 in the PCR 
reaction. 
2.5 MEASUREMENT OF CYTOKINE LEVELS BY ENZYME-LINKED 
IMMUNOSORBENT ASSAY 
The levels of IL-1β, and TNF-α in serum of infected mice or produced by the knockout and WT 
control BMM in culture supernatants were determined by commercially available enzyme-linked 
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immunosorbent assay (ELISA (eBioscience, San Diego, CA; Vienna, Austria)) kits according to 
the manufacturer’s instructions.  
2.6 PROTEIN EXTRACTION AND WESTERN BLOT ANALYSIS 
Liver tissues and BMMs were lysed in T-PER lysis buffer or RIPA buffer (Thermo Fisher 
Scientific, Waltham, MA), respectively, supplemented with protease inhibitors and 1 mM 
phenylmethylsulphonyl fluoride (PMSF). Cell debris was removed by centrifugation. Protein 
extraction was performed at 4°C for 30 min. The protein content of the lysates was measured 
using a Bicinchoninic Acid Assay Kit (Pierce). Lysates (15-30 ug) were resolved in 4% to 20% 
gradient SDS–PAGE under reducing conditions. After electrophoresis, proteins were transferred 
onto PVDF membranes (BioRad) and blocked for 1 h in Tris-buffered saline (TBS) containing 
5% non-fat milk and 0.1% Tween 20. Blots were probed with the appropriate primary antibodies 
and peroxidase-conjugated bovine anti-rabbit secondary antibodies (1:10000) (Santa Cruz 
Biotechnology). The membranes were processed and probed with the following antibodies, 
according to standard protocols: anti–caspase-1 (2 μg/mL) (EMD Millipore, Billerica, MA); anti-
LC3B (dilution 1:1000) (Sigma-Aldrich, St. Louis, MO). Specific signals were developed using 
the ECL-Plus system (GE). Blots were stripped with Restore Western Blot Stripping Buffer 
(Pierce) and re-probed with GAPDH (dilution 1:5000). Mean pixel density of bands in Western 
blots was determined using ImageJ software version 1.48 (NIH, Bethesda, MD). 
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2.7 HISTOPATHOLOGY AND TERMINAL DEOXYNUCLEOTIDYL 
TRANSFERASE D-UTP NICK END LABELING (TUNEL) ASSAY 
Tissue sections were fixed in a 10% solution of neutral buffered formalin, dehydrated in graded 
alcohols, embedded in paraffin wax, and stained with hematoxylin and eosin (H&E). Semi-
quantitative analysis of the liver lesions was carried out using three parameters: the number of 
necrotic cells, the number of apoptotic cells, and the number of inflammatory foci in each high-
power field (HPF). TUNEL staining was performed on unstained tissue sections, showing 
apoptotic cell death without focal necrosis, as described previously. 
2.8 STATISTICAL ANALYSIS 
All the data presented are representative of two or three independent experiments that yielded 
similar results. Two groups analysis was performed using an unpaired two-tailed t test. For 
comparison of multiple experimental groups, we used one –way analysis of variance (ANOVA) 
with Bonferroni’s procedure. To determine whether the difference in survival between different 
mice groups was significant, data were analyzed by the Breslow-Wilcoxon Test. All statistical 
analyses were performed using GraphPad Prism (GraphPad Software Inc., La Jolla, CA, USA). 
Data are represented by means and standard deviations (SD). Differences with P values of 0.05, 
0.01, and 0.001 were considered slightly (*), moderately (**), and highly (***) significant, 
respectively. 
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3.0  RESULTS 
3.1 MYD88 SIGNALING PROMOTES EHRLICHIA-INDUCED 
IMMUNOPATHOLOGY AND SUSCEPTIBILITY TO FATAL EHRLICHIOSIS  
Ehrlichia-induced toxic shock is caused by immunopathology and excessive inflammation [8, 
28, 29]. To investigate the role of MyD88 in the pathogenesis of ehrlichiosis, we analyzed host 
response to Ehrlichia in WT and MyD88-/- mice infected with a high dose of IOE. 100% of IOE-
infected WT mice succumbed to lethal infection on days 7-9 post-infection (p.i.) In contrast, 
~70% of MyD88-/- mice succumbed to infection at that time point (P=0.0084) (Fig. 1A), and 
these mice have a significantly higher bacterial burden in the liver on day 7 p.i. when compared 
to WT mice (Fig. 1B). Interestingly, the lack of MyD88 signaling attenuated liver injury as 
evidenced by significantly decreased apoptotic (TUNEL positive) hepatocytes and Kupffer cells. 
Further, H&E staining demonstrated reduced magnitude of fatty changes/steatosis and necrosis 
in the liver of infected MyD88-/- mice (as shown by H&E staining) when compared to WT mice 
(Fig. 1C).  
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Figure 1. MyD88 deficiency increases IOE bacterial burden but increases survival and 
reduces liver pathology. A) IOE infected MyD88 mice show a significantly higher IOE copy 
number than Wt mice. B) IOE infected MyD88 deficient mice have an improved survival rate when 
compared to infected Wt mice. C) TUNEL staining of murine liver tissue showing that MyD88 
deficiency attenuates IOE mediated liver pathology when compared to infected Wt mice. Error bars 
represent standard deviation of the mean. Asterisks represent p values below 0.05. 
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3.2 MYD88 PROMOTES CANONICAL INFLAMMASOME ACTIVATION IN 
MACROPHAGES 
We examined the contribution of MyD88 to inflammasome activation during IOE infection. To 
this end, we measured the expression of active caspase-1 in the liver lysates from WT and 
MyD88-/- mice by immunoblotting. IOE infection elicited inflammasome activation in the liver 
of WT mice as evidenced by increased caspase 1 activation (Fig. 2A), and high IL-1β serum 
levels on day 7 p.i. (Fig. 2B).  In contrast, MyD88 deficiency inhibited caspase-1 activation in 
the liver tissues (Fig. 2A) and decreased serum levels of IL-1β (Fig. 2B). These data suggested 
that MyD88 mediates Ehrlichia-induced inflammasome activation.   
IOE triggered production of canonical NF-κB-dependent cytokines and the 
inflammasome-independent cytokine TNF-α in serum (Fig. 2C) and BMMs (Fig. 2D) in a 
MyD88 dependent manner. IOE infection induced MyD88 dependent activation of caspase-1 and 
secretion of IL-1β and IL-1α in BMMs (Fig. 2A, 2E, 2F). Secretion of IL-1β is considered a 
marker of non-canonical inflammasome activation mediated by active caspase 1 and caspase 11. 
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 Figure 2. MyD88 is necessary for IOE mediated inflammasome activation. A) IOE 
infection induces a caspase 1 that is abrogated in MyD88 deficient mice, both in vivo from 
liver lysates and in vitro from bone marrow macrophages (BMM). B) IOE infection 
increases IL-1β C) and TNF-α production in vivo, and these increases are reduced in MyD88 
deficient mice as determined by immunosorbent assay with serum collected from infected 
and naïve mice at 7 days post infection. D) IOE infection increases IL-1β E) and TNF-α 
production in vitro using bone marrow derived macrophages from Wt mice. These increases 
are reduced in cells from MyD88 deficient mice. Error bars express standard deviation of 
the mean. Asterixis indicate a p value below 0.05. 
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3.3 MYD88 INHIBITS AUTOPHAGY INDUCTION IN INFECTED MACROPHAGES  
Heightened susceptibility of mice to fatal ehrlichiosis is associated with suppression of 
autophagy initiation in liver [30]. Thus, we hypothesized that MyD88 could promote 
inflammasome activation in vivo via autophagy regulation. To test this hypothesis, we examined 
LC3 II accumulation in infected liver tissues from IOE-infected mice by immunoblotting. 
Compared to uninfected WT mice, liver lysates from IOE-infected WT mice, on day 7 p.i. 
showed reduced LC3II conversion and thus a lower LC3II: I ratio (Fig. 3A).  Liver lysates from 
IOE-infected MyD88-/- mice expressed more LC3II, and thus had a higher LC3II:I ratio than 
naïve MyD88-/- or infected WT mice. This suggests that IOE mediates autophagy inhibition, 
partially via MyD88 signaling.  
Next, we examined autophagy induction and flux in infected macrophages from WT and 
MYD88-/- mice. Consistent with in vivo data, IOE infection of WT-BMMs failed to induce LC3 
conversion from I to II (Fig. 3B), while infection of MYD88-/- BMMs increased LC3 conversion 
it decreased LC3II conversion in the liver lysates and BMMs from IOE-infected WT, but not in 
MYD88-/-, mice could be due to defective initiation of autophagy or enhanced autophagosomal 
degradation. To differentiate between these processes, we examined expression of beclin-1 as a 
key protein in the initiation of autophagosome formation [31-33]. Our data showed similar 
beclin-1 expression in IOE-infected WT BMM 24hr p.i. when compared to naïve cells (Fig. 3C).  
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Figure 3. MyD88 is necessary for IOE mediated autophagy regulation via mTORC1. A) 
Phosphorylation of mTORC1 activation marker Ribosomal S6 (1:5000, Cell Signaling) is 
increased IOE infection (moi 1/20), and this affect is abrogated in MyD88 deficient mice. 
Conversion of LC3 II (1:1000, Sigma Aldrich) is reduced in vivo with IOE infection, but 
accumulates in MyD88 deficient mice regardless of IOE infection. B) S6 Phosphorylation is 
increased, and conversion of LC3 I to II is reduced in cultured bone marrow derived 
macrophages with IOE infection. C) Beclin I (1:1000, Cell Signaling) accumulates with IOE 
infection. 
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To determine whether autophagosomal-lysosomal fusion was occurring confocal 
microscopy was performed. IOE infected cells were stained for LC3 and the lysosomal pH 
marker LysoTracker Deep Red. Infected WT BMMs, exhibited LC3 puncta formation, but very 
little co-localized with the lysosome (shown as yellow), which indicated fusion (Fig. 4). Both 
puncta formation and fusion were far lower during IOE infection than that induced by LPS 
stimulation. This suggests that absence of LPS in Ehrlichia may provide an immune evasion 
strategy. These data re-enforce the conclusion that IOE infection inhibits autophagosome-
lysosomal fusion in macrophages.  
 
 
Figure 4. Autophagy flux is reduced during IOE infection compared to LPS control. 
Confocal microscopy (100x) showing immunofluorescent staining of bone marrow derived 
macrophages for LC3 (1:200) and lysosomal pH (LysoTracker Deep Red) during IOE infection 
(moi 1/20) and when stimulated with LPS control (200 ng/mL). Co-localization of active 
lysosomes and LC3 puncta indicate autophagosomal-lysosomal fusion. 
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3.4 MYD88-MEDIATED INHIBITION OF AUTOPHAGY INDUCTION IN 
INFECTED MACROPHAGES IS MEDIATED VIA MTORC1 ACTIVATION  
Activation of mTORC1 negatively regulates autophagy [34]. To investigate the mechanism of 
MyD88-dependent autophagy inhibition during IOE infection, we first examined mTORC1 
activation in vivo. mTORC1 activation is measured by phosphorylation of its downstream target 
ribosomal protein S6 (pS6). Infected WT mice had elevated pS6 in the liver on day 7 p.i., while 
infected MyD88-/- mice lacked pS6 at the same time point (Fig. 3A).  
 To confirm the in vivo data, we examined mTORC1 activation in in vitro infected 
BMMs. Immunoblotting revealed a clear increase in pS6 in infected Wt BMMs post infection, 
consistent with the in vivo findings (Fig. 3B).  
3.5 VIRULENT EHRLICHIA INDUCES MITOCHONDRIAL DAMAGE AND 
MYD88-DEPENDENT P62 ACCUMULATION IN MACROPHAGES. 
LPS stimulation of macrophages induces NF-κB-dependent p62 accumulation, promoting 
elimination of damaged mitochondria and preventing inflammasome activation [35-37]. Thus, 
we hypothesized that MyD88-mediated inflammasome activation in macrophages and liver 
injury following IOE infection is due to defective mitophagy. To test this hypothesis, began by 
examining the ultrastructure of infected cells using transmission electron microscopy (TEM).  
Our data indicated that infected WT BMMs had fewer double-membrane autophagosomes and 
autolysosomes, and damaged mitochondria when compared to uninfected WT BMMs (Fig. 5A). 
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These data suggest that IOE infection induces mitochondrial damage in macrophages that fail to 
be eliminated due to inhibition of autophagy flux and thus mitophagy. 
To confirm IOE mediated mitochondrial damage we stained BMMs for p62 and the 
mitochondrial marker MitoTracker Deep Red. Immunofluorescence staining demonstrated an 
increased in p62 puncta in infected WT-BMMs, but decreased colocalization with the 
mitotracker when compared to LPS control (Fig. 5B). Though p62 levels appear lover in 
immunofluorescent imaging, immunoblotting demonstrated that uninfected and IOE-infected 
WT BMMs expressed similar levels of p62 (Fig. 5C). However, p62 levels were significantly 
lower in IOE-infected MyD88-/- BMMs compared to infected WT BMMs and uninfected 
MyD88-/-BMMs (Fig. 5C). We postulated that decreased p62 in infected MyD88-/- BMMs could 
be the results of rapid degradation via autophagy flux [35, 38, 39]. Alternatively, it is possible 
that decreased NF-κB activation, secondary to MyD88 deficiency, could account for decreased 
p62. To test this, we measured the expression of phosphorylated p38 mitogen-activated protein 
kinase (MAPK), as a marker of NF-κB activation [40]. The expression of p38 MAPK was 
indeed abolished in MyD88-/- BMMs (Fig. 5D), suggesting that MyD88-dependent NF-κB 
activation in infected macrophages could contribute to decreased p62 in MyD88-/- BMMs.  
 
 
 
 
 
 20 
 
 
Figure 5. IOE infection induces mitochondrial damage. A) Electron microscopy of bone marrow 
derived macrophages showing that IOE (moi 1/20) increases autophagosome formation and 
mitochondrial damage in similar manner to LPS (200 ng/mL) control. B) Fluorescent microscopy 
(100X) staining for p62 (1:50 Cell Signaling) and MitroTracker Deep Red. Colocalization of 
mitochondria and the ubiquitination marker p62 indicate damaged mitochondria. C) Levels of p62 
remain steady with IOE infection in Wt cells, but reduce with MyD88 deficiency, potentially 
indicating a reduction in damaged cell components or an increase in degradation. D) Levels of p38 
(1:1000, Cell Signaling) increase with IOE infection in WT BMM, but decrease with IOE infection 
in MyD88-/- BMM. 
 21 
3.6 TLR9 IS THE UPSTREAM SIGNAL THAT MEDIATES MYD88-DEPENDENT 
MTORC1 ACTIVATION AND INFLAMMASOME ACTIVATION.  
Virulent IOE infection triggers upregulation of several TLRs in liver tissue of infected mice 
including TLR2, TLR7, and TLR9 [3]. To determine the TLR that mediates MyD88-dependent 
mTORC1 and inflammasome activation, we compared IL-1β production and expression of pS6 
in BMMs from TLR2-/-, TLR7-/-, and TLR9-/- mice to that expressed in WT BMMs. Infection of 
TLR2-/- and TLR7-/- BMMs elicited IL-1β, albeit at slightly lower levels than WT BMMs (Fig. 
6A). In contrast, infection of TLR9-/- BMMs did not elicit IL-1β production, and abrogated 
infection induced S6 phosphorylation when compared to WT, TLR2-/-, or TLR7-/- macrophages 
(Fig. 6B). Thus, these data suggest that TLR9 is the major upstream pathway that mediates 
MyD88-dependent activation of mTORC1 and inflammasome activation during Ehrlichia 
infection. 
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Figure 6. IOE mediated autophagy regulation and inflammasome activation is TLR 9 dependent. 
A) Immunoblot analysis for ribosomal S6 phosphorylation (1:5000, Cell Signaling) in wild-type, TLR2-/-
, TLR7-/-, and TLR9-/-  murine bone marrow derived macrophage lysates at 24 hr post IOE (moi 1/20) 
infection. Left margin, molecular size in kilodaltons (kDa). B) IL-1β (pg/mL) in WT and TLR9-/- BMM 
cell supernatants infected with IOE (moi 20) and stimulated with IFN-β (400 units/mL) determined by 
ELISA. Error bars express standard deviation of the mean. Asterix indicate a p value below 0.05. 
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To further investigate the role of TLR9 in IOE infection we compared expression of 
phosphorylated S6 and production of IL-1β in BMMs from IOE infected TLR9-/- mice which had 
also been stimulated with IFN-β, and compared the response to WT BMMs. Interestingly, 
attenuation S6 phosphorylation and reduced IL-1β secretion in TLR9-/- BMMs compared to Wt 
BMM occurred even with the addition of IFN-β (Fig 7A, B). Abrogation of S6 phosphorylation 
even occurred during LPS stimulation. These data indicate that TLR9 is the major upstream 
pathway that mediates MYD88-dependent activation of mTORC1 and autophagy inhibition 
during Ehrlichia infection, which in turn elicits inflammasome activation. 
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3.7 IFNΒ ACTS AS AN AUTOPHAGY SUPPRESSOR DURING VIRULENMT 
EHRLICHIA INFECTION 
Our previous work has shown that IFN mRNA levels vary between the Ehrlichia strains IOE and 
EM, with the more virulent IOE showing much higher IFN mRNA levels. This is differential 
IFN expression is supported by serum IFN levels detected in serum taken from in vivo murine 
IOE and EM infection over a 7-day time course (Fig. 7B). These data demonstrate that the 
variation in IFN mRNA expression between IOE and EM Ehrlichia strains is perpetuation into 
translation, verifying a physiologically relevant change. 
Figure 7. IOE, IFN-β, and LPS mediated autophagy regulation and inflammasome 
activation is TLR 9 dependent. A) Immunoblot analysis for ribosomal S6 phosphorylation 
(1:5000, Cell Signaling) in wild-type and TLR9-/-  murine bone marrow derived macrophage 
lysates with and without IFN-β (400 units/mL), IOE (moi 20), and LPS (1μg/mL) stimulation for 
24 hours. Left margin, molecular size in kilodaltons (kDa). B) IL-1β (pg/mL) in WT and TLR9-
/- BMM cell supernatants infected with IOE (moi 1/20) and stimulated with IFN-β (400 
units/mL) determined by ELISA. Error bars express standard deviation of the mean. 
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3.8 EFFECT OF INFECTION WITH EXTRACELLULAR BACTERIA ON 
AUTOPHAGY IN MURINE MACROPHAGES 
Figure 8. IFNβ plays a role in IOE mediated autophagy regulation. A) Phosphorylation of mTORC1 
marker ribosomal S6 (1:5000, Cell Signaling), and LC3 I:II conversion (Sigma Aldrich 1:1000) 
indicating that IFNβ (400 units / mL) is needed to fully recapitulate in vivo IOE (moi 1/20) mediated 
mTORC1 activity. B) IFNβ (pg/mL) levels determined from serum of EM and IOE i.p. infected mice at 
3, 5, and 7 days post infection using ELISA. Data indicate that IFNβ levels rise only in the virulent IOE, 
and only as mice approach the terminal end of infection. 
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As our study depends on the use of Ehrlichia as a broad model for innate immune response, we 
used the bacteria Staphylococcus aureus (Fig. 9A) and Acinetobacter baumannii (Fig. 9B) at a 
series of multiplicity of infections (MOI) and time points to test the autophagy response in vitro 
with protein from infected murine bone marrow derived macrophages. Here both the increased 
S6 phosphorylation and low LC3 II:I ratio observed with IOE also occur during both A. 
baumannii and S. aureus infection. 
 
 
Figure 9. Extracellular infection shows similar autophagy response in murine BMM. 
Ribosomal S6 phosphorylation (1:5000 Cell Signaling) and LC3 I and II (1:1000 Sigma 
Aldrich) levels in murine bone marrow derived macrophages infected with 1, 10, or 50 moi 
S. aureus or A. baumannii collected at 2, 4, 8, or 24 hours to assess kinetic autophagy 
progression. 
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4.0  DISCUSSION 
Ehrlichia infection induces deleterious inflammasome activation, which contributes to excessive 
inflammation and organ damage in the murine model of fatal ehrlichiosis. However, the 
downstream adaptor molecules that mediate signaling during Ehrlichia infection as well as the 
molecular mechanisms that regulate inflammasome activation during infection with Ehrlichia 
remain unknown. MYD88 signaling functions as an immune evasion mechanism, inhibiting 
mTORC1 dependent autophagy and inducing inflammasome activation. These data are 
consistent with the previously established deficiency in E. muris clearance from MyD88 
deficient mice [41] [42]. We have also shown that virulent IOE triggers inflammasome activation 
marked by upregulation of NLRP3, cleavage of caspase 1, and secretion of IL-1β [3, 27]. We 
demonstrate that MYD88 signaling contributes to caspase 1 activation and IL-1β secretion in 
vivo and in vitro in infected macrophages.  
Autophagy is a critical innate immune defense mechanism against several facultative 
intracellular bacterial pathogens such as Legionella and Salmonella. However, the role of 
autophagy in protective innate immunity against infection with obligate intracellular virulent 
bacteria such as Ehrlichia is not clearly defined. Autophagy does have an established negative 
correlation with inflammasome activation currently ties to its role in the elimination of both 
microbial and host danger ligands that activate inflammasome complexes [43]. We show that 
IOE-induced MYD88 signaling blocks autophagy via activation of the mTORC1 pathway. 
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Additionally, we found that TLR9 is a key upstream receptor for IOE mediated autophagy 
suppression during virulent Ehrlichia infection. Though it is not yet clear how TLR9 is triggered 
during virulent Ehrlichia infection, it is possible that TLR9 is responding to DAMPs [15] 
released as a result of IOE mediated cell damage as well as responding to IOE DNA directly. 
TLR9 activation, in murine bone marrow derived macrophages, is essential for IOE mediated 
mTORC1 activation. This mTORC1 activation suppresses the canonical mTORC1 dependent 
autophagy, and results in DAMP accumulation that can release TLR9 activating DAMPS and 
result in a positive feedback loop of reinforced mTORC1 activation (Fig. 10). This positive 
feedback loop would minimize potential Ehrlichia degradation in the cell. Surprisingly, lack of 
TLR9 both abrogated mTORC1 activation and attenuated IL-1β secretion in response to IOE 
infection as well as LPS and IFNβ stimulation when compared to WT-BMMs (Fig. 7). Our 
model uniquely highlights a novel mechanism for regulation of autophagy and inflammasome 
activation during infection. Future studies will define key host and/or microbial molecules that 
induce TLR9/MYD88-mediated mTORC1-dependent autophagy inhibition and inflammasome 
activation during infection with LPS-negative Ehrlichia.  
The balance between protective immunity and immunopathology during Ehrlichia 
infection determines outcome. In this study, we demonstrate that autophagy is not only a host-
protective mechanism that mediates elimination of Ehrlichia, but is also critical for clearance of 
damaged mitochondria through mitophagy. Indeed, elimination of damaged mitochondria is 
important to maintain cellular homeostasis and prevent excessive inflammation and cellular 
injury. Virulent IOE infection induces mitochondrial damage in both macrophages and 
hepatocytes. Ehrlichia chaffeensis, a strain closely related to IOE, inhibits mitochondrial 
activities and metabolism [44, 45]. Ehrlichia harbor several effector proteins that are secreted via 
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type I and IV secretion systems [46]. These proteins are translocated from the bacterium residing 
in the phagosome into the host cell cytoplasm and localized to the mitochondria [44].  It has been 
shown that upregulation of mitochondrial manganese superoxide dismutase (MnSOD) within E. 
chaffeensis infected macrophages prevent reactive oxygen species (ROS)-induced cellular 
damage and apoptosis. E. chaffeensis causes mild disease in WT mice. Thus, it is possible that 
infection with virulent IOE causes mitochondrial damage in infected macrophages by increasing 
ROS without inducing MnSOD[46]. Nevertheless, we show here that MyD88 blocks 
mitochondrial autophagy in macrophages by blocking autophagy flux and co-localization of p62 
with damaged mitochondria. Further, lack of p62 degradation in infected cells may result in 
further cytotoxicity. Indeed, attenuated apoptosis and necrosis of hepatocytes and Kupffer cells 
in the liver of IOE-infected MyD88-/- mice further suggest that MyD88 induces liver injury via 
inhibition of autophagy induction and flux in macrophages and inhibition of mitophagy in 
hepatocytes.   
The Ehrlichia ligand that triggers host-pathogenic inflammasome activation remains 
elusive. Though Ehrlichia tandem repeat proteins (TRPs) and type I and IV secretion system 
effectors are potential candidates for activation, secretion of these proteins into host cell cytosol 
[47] would enable them to trigger cytosolic NLRs. Alternatively, accumulation of mitochondrial 
DNA (mtDNA) or increased reactive oxygen species (ROS) in IOE- infected macrophages could 
act as DAMPS responsible for inflammasome activation. In support of this conclusion, our data 
show that MyD88-dependent mTORC1 activation is mediated via TLR9, an endosomal TLR that 
is triggered by microbial or host DNA including mtDNA. On the other hand, our data show that 
blocking bacterial internalization by Dynasore treatment abrogates mTORC1 activation in 
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infected macrophages, suggesting that TLR9 signals and subsequent mTORC1 activation are 
also triggered, by microbial DNA or DNA-binding Ehrlichia protein.  
This is the first study to reveal a novel mechanism whereby virulent Ehrlichia exploits 
the MyD88-mTORC1-autophagy pathway to: evade host innate immune responses, elicit host-
pathogenic inflammasome activation, induce inflammatory macrophage death, and induce liver 
injury. Inhibition of autophagy in macrophages, the main target cells, together with induction of 
host cell death enhances not only intracellular bacterial survival, but also dissemination and 
multi-organ injury. Our results highlight a potential role for mitochondrial damage in Ehrlichia-
induced macrophage death. In conclusion, this study shows, for the first time, that obligate 
intracellular Ehrlichia exploits the AKT-mTORC1 pathway to evade autophagy and intracellular 
killing. Our current working model proposes that signaling via TLR9 and MyD88 elicit 
mTORC1 activation, which blocks autophagy initiation in macrophages and hinders adaptive 
immunity against Ehrlichia (Fig. 10). Thus, targeting the mTORC1 pathway and identifying key 
PAMPs and DAMPs that induce MyD88 signaling, autophagy inhibition and inflammasome 
activation provides novel therapeutic approaches for the treatment and prevention of this 
important disease. 
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Figure 10. Working hypothesis. Summary figure showing that IFNβ seems to be acting 
upstream of TLR9, MyD88, and mTORC1 activation in macrophages. This activation may be 
tied to DAMP and PAMP production during the inflammatory response, and does not address 
the mechanism for production of initial IFN-β. 
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